n-acetylneuraminic acid has been researched along with Endometriosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Carpen, O; Gidwani, K; Heinosalo, T; Huhtinen, K; Hynninen, J; Kekki, H; Lamminmäki, U; Nadeem, N; Perheentupa, A; Pettersson, K; Poutanen, M | 1 |
Jędryka, M; Kratz, EM; Krotkiewski, H; Sołkiewicz, K | 1 |
Choi, HJ; Choi, JH; Chung, TW; Ha, KT; Han, JH; Kim, CH | 1 |
Hasumi, K; Masubuchi, K; Okudaira, Y; Shimizu, Y | 1 |
1 trial(s) available for n-acetylneuraminic acid and Endometriosis
Article | Year |
---|---|
Variability of serum IgG sialylation and galactosylation degree in women with advanced endometriosis.
Topics: Adult; Endometriosis; Female; Glycosylation; Humans; Immunoglobulin G; N-Acetylneuraminic Acid | 2021 |
3 other study(ies) available for n-acetylneuraminic acid and Endometriosis
Article | Year |
---|---|
Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cross Reactions; Diagnosis, Differential; Endometriosis; Europium; Female; Humans; Immunoassay; Metal Nanoparticles; N-Acetylneuraminic Acid; Neoplasm Grading; Ovarian Neoplasms; ROC Curve | 2019 |
Increased α2-6 sialylation of endometrial cells contributes to the development of endometriosis.
Topics: Animals; beta-D-Galactoside alpha 2-6-Sialyltransferase; Cell Line, Tumor; Disease Models, Animal; Endometriosis; Endometrium; Epithelium; Female; Focal Adhesions; Humans; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Peritoneum; RNA, Small Interfering; Sialic Acid Binding Immunoglobulin-like Lectins; Sialyltransferases; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2018 |
Management of patients with gynecologic cancer by serum sialic acid determination.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Biomarkers, Tumor; Combined Modality Therapy; Endometriosis; Female; Genital Neoplasms, Female; Humans; Middle Aged; Myoma; N-Acetylneuraminic Acid; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Sialic Acids; Teratoma; Uterine Neoplasms | 1989 |